Market closedNon-fractionalADR
Novartis/NVS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Novartis
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Ticker
NVS
Sector
Healthcare
Trading on
NYSE
Industry
Pharmaceuticals
Headquarters
Basel, Switzerland
Employees
76,057
Website
www.novartis.com
Novartis Metrics
BasicAdvanced
$223B
Market cap
14.03
P/E ratio
$7.84
EPS
0.49
Beta
$3.92
Dividend rate
3.56%
Dividend yield
Price and volume
Market cap
$223B
Beta
0.49
Dividend rate
$3.92
Financial strength
Current ratio
0.931
Quick ratio
0.612
Long term debt to equity
50.649
Total debt to equity
69.178
Dividend payout ratio (TTM)
47.13%
Interest coverage (TTM)
16.70%
Management effectiveness
Return on assets (TTM)
9.07%
Return on equity (TTM)
21.50%
Valuation
Price to earnings (TTM)
14.028
Price to revenue (TTM)
4.606
Price to book
4.7
Price to tangible book (TTM)
-17.4
Price to free cash flow (TTM)
16.597
Dividend yield (TTM)
3.56%
Growth
Revenue change (TTM)
9.70%
Earnings per share change (TTM)
118.29%
3-year revenue growth (CAGR)
-1.77%
3-year earnings per share growth (CAGR)
25.68%
3-year dividend per share growth (CAGR)
4.94%
What the Analysts think about Novartis
Analyst Ratings
Majority rating from 11 analysts.
Novartis Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$12B
2.92%
Net income
$2.7B
-68.30%
Profit margin
22.17%
-69.21%
Novartis Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$1.83
$1.83
$1.53
$1.80
-
Expected
$1.68
$1.70
$1.69
$1.69
$1.86
Surprise
8.68%
7.86%
-9.20%
6.76%
-
Novartis News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractionalADR
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Novartis stock?
Novartis (NVS) has a market cap of $223B as of July 27, 2024.
What is the P/E ratio for Novartis stock?
The price to earnings (P/E) ratio for Novartis (NVS) stock is 14.03 as of July 27, 2024.
Does Novartis stock pay dividends?
Yes, the Novartis (NVS) stock pays dividends to shareholders. As of July 27, 2024, the dividend rate is $3.91896 and the yield is 3.56%. Novartis has a payout ratio of 47.13% on a trailing twelve-month basis.
When is the next Novartis dividend payment date?
The next Novartis (NVS) dividend payment date is unconfirmed.
What is the beta indicator for Novartis?
Novartis (NVS) has a beta rating of 0.49. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Novartis stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.